CD4 and neoplasm: Analysis of ID8 s.c. tumors immune profile revealed that TAX2 treatment not only increases the number of infiltrating CD4+ (Figure 4c,e), but also stimulates deeper T-cell infiltration within the whole tumor sections (Figure 4d).